Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.

@article{Ascaso2007ManagementOD,
  title={Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.},
  author={Juan Francisco Ascaso and Pedro Gonz{\'a}lez Santos and Antonio Hern{\'a}ndez Mijares and Alipio Mangas Rojas and Llu{\'i}s Masana and Jes{\'u}s Mill{\'a}n and Lu{\'i}s Felipe Pallardo and Juan Carlos Pedro-Botet and Francisco P{\'e}rez Jim{\'e}nez and Xavier Pint{\'o} and Ignacio Maga{\~n}a Plaza and Juan Rubi{\'e}s and Manuel Z{\'u}{\~n}iga},
  journal={American journal of cardiovascular drugs : drugs, devices, and other interventions},
  year={2007},
  volume={7 1},
  pages={39-58}
}
In order to characterize the metabolic syndrome it becomes necessary to establish a number of diagnostic criteria. Because of its impact on cardiovascular morbidity/mortality, considerable attention has been focussed on the dyslipidemia accompanying the metabolic syndrome. The aim of this review is to highlight the fundamental aspects of the pathophysiology, diagnosis, and the treatment of the metabolic syndrome dyslipidemia with recommendations to clinicians. The clinical expression of the… CONTINUE READING